EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Testing of an Owner‐Reported Outcome Measure of Clinical Signs and Quality of Life in Dogs Treated With Chemotherapy

Jenny Harris iD, Katie Sutton iD, Quentin Fournier iD, Jo Armes iD, Emma Ream iD, Nicholas Bacon iD

Veterinary and Comparative Oncology · 2026

DOI: 10.1111/vco.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2026. Verfasst von Jenny Harris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, UK. Hauptthemen laut MEDLINE: Quality of Life, Dog Diseases, Antineoplastic Agents, Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Kennel Club Charitable Trust, UK, Kennel Club Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a leading cause of mortality in older dogs. Despite the prevalence of chemotherapy in canine oncology, a good understanding of owners' observations of side effects and clinical signs in real time is still lacking. Owners' perceptions and reporting of clinical signs play an important role in monitoring a dog's condition during treatment and the use of digital owner‐reported outcome measures could prove efficient in tracking chemotherapy side effects in the home environment. This could improve care and draws inspiration from the human use of patient‐reported outcome measures in oncology. We aimed to develop and test a prototype digital measure for monitoring clinical signs and health‐related quality of life in dogs undergoing chemotherapy, designed to facilitate owner participation in monitoring and support veterinary care. A rapid literature review was conducted to identify existing measures and their methodological limitations. Items were generated based on the Veterinary Comparative Oncology Group‐Common Terminology Criteria for Adverse Events, existing client‐reported outcome measures, and expert veterinary opinion. Proof‐of‐Concept testing was performed with 29 dog owners with pets undergoing chemotherapy. Participants completed daily assessments of their dog's clinical signs and weekly quality of life surveys over a 21‐day period. A sub‐sample participated in cognitive interviews to assess content validity and acceptability. Descriptive statistics were used to assess clinical signs and quality of life scores. Internal consistency and item discrimination were evaluated, and qualitative data were analyzed thematically. High adherence was reported, with a median of 21 daily and 3 weekly assessments completed. Participants found the assessments acceptable and beneficial. Fatigue, polydipsia, and anorexia were the most frequently reported clinical signs. Dogs experienced a median of 3 different clinical signs. The quality‐of‐life scale showed good internal consistency (Cronbach's α = 0.84). Participants appreciated the daily assessments, found them easy to complete, and believed the measure could help improve monitoring and decision‐making during chemotherapy. The prototype tool, the Canine Cancer Outcome Measure (CAN‐COM), demonstrated feasibility and acceptability for use by owners in the home environment for dogs undergoing chemotherapy. With further refinement and validation, such a tool could improve the monitoring of adverse events and support decision‐making in veterinary oncology, enhancing the welfare of canine cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeDog DiseasesAntineoplastic AgentsNeoplasmsPatient Reported Outcome MeasuresDogsAnimalsMaleFemaleHumansOwnershipSurveys and Questionnaires

Stichwörter der Autor:innen

adverse events monitoringcanine oncologychemotherapyclient‐reported outcome measuresclinical signsquality of lifeveterinary palliative care

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Health and Medical Sciences, School of Health Sciences, University of Surrey, Guildford, UK.
  • Lumbry Park Veterinary Specialists, Alton, UK.
  • AURA Veterinary, Guildford, UK.
  • Faculty of Health and Medical Sciences, School of Veterinary Medicine, University of Surrey, Guildford, UK.

ORCID-Profile: Jenny Harris, Katie Sutton, Quentin Fournier, Jo Armes, Emma Ream, Nicholas Bacon

Förderung

  • The Kennel Club Charitable Trust, UK
  • Kennel Club Charitable Trust

Zitieren

APA

Harris, J., Sutton, K., Fournier, Q., Armes, J., Ream, E., & Bacon, N. (2026). Development and Testing of an Owner‐Reported Outcome Measure of Clinical Signs and Quality of Life in Dogs Treated With Chemotherapy. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70028

Vancouver

Harris J, Sutton K, Fournier Q, Armes J, Ream E, Bacon N. Development and Testing of an Owner‐Reported Outcome Measure of Clinical Signs and Quality of Life in Dogs Treated With Chemotherapy. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70028

BibTeX
@article{Harris2026,
  author = {Harris, Jenny and Sutton, Katie and Fournier, Quentin and Armes, Jo and Ream, Emma and Bacon, Nicholas},
  title = {Development and Testing of an Owner‐Reported Outcome Measure of Clinical Signs and Quality of Life in Dogs Treated With Chemotherapy},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  doi = {10.1111/vco.70028}
}
Kostenlos starten →